First Patient Dosed in VIRO-25 Trial of Olvimulogene Nanivacirepvec for NSCLC
Recovering Stroke Patients Endure Long-Term Depression Driven by Many Factors
Potential Groundbreaking Biomarker for Immunotherapy Assessment Across Breast Cancer